Estrogen replacement therapy, serum lipids, and polymorphism of the apolipoprotein E gene - PubMed (original) (raw)
Clinical Trial
. 1999 Aug;45(8 Pt 1):1214-23.
Affiliations
- PMID: 10430787
Clinical Trial
Estrogen replacement therapy, serum lipids, and polymorphism of the apolipoprotein E gene
P J Garry et al. Clin Chem. 1999 Aug.
Abstract
Background: Pharmacogenomics, the study of genetic loci that modulate drug responsiveness, may help to explain why estrogen replacement therapy (ERT) has differential effects on serum lipid and lipoprotein concentrations in postmenopausal women who inherit distinct alleles of the apolipoprotein E gene (APOE).
Methods: We compared total-cholesterol, triglyceride, and lipoprotein (LDL and HDL) concentrations in 66 postmenopausal women receiving ERT ([+]ERT) with 174 postmenopausal women not receiving ERT ([-]ERT), controlling for three APOE genotypes divided into three groups: E2 (epsilon2/epsilon3, n = 31), E3 (epsilon3/epsilon3, n = 160), and E4 (epsilon3/epsilon4 + epsilon4/epsilon4, n = 49).
Results: Mean total-cholesterol concentrations were lower in all three [+]ERT groups compared with their [-]ERT counterparts but were statistically significant only for women in group E4 (P = 0.014). The mean LDL-cholesterol concentrations were significantly lower in all three [+]ERT groups compared with their [-]ERT counterparts (P </=0.005). Although all three groups of [+]ERT women tended to have higher mean HDL-cholesterol concentrations compared with their [-]ERT counterparts, the differences were not statistically significant. [+]ERT women in groups E2 and E3 had significantly higher (P <0.05) triglyceride concentrations than their [-]ERT counterparts. In [+]ERT women, the ratios of total and LDL-cholesterol to HDL-cholesterol were significantly higher in group E3 and E4 women compared with E2 women (P <0.006). Group E4 [+]ERT women had ratios of total and LDL-cholesterol to HDL-cholesterol that were comparable to group E2 [-]ERT women.
Conclusions: Triglyceride concentrations in group E2 [+]ERT women may need to be monitored more closely than those in E3 or E4 [+]ERT women. Group E4 women should probably be targeted for ERT. Results suggest that APOE genotypes have a differential effect on serum lipids and lipoproteins in [+]ERT postmenopausal women.
Similar articles
- Apolipoprotein E genotype and response of lipid levels to postmenopausal estrogen use.
von Muhlen D, Barrett-Connor E, Kritz-Silverstein D. von Muhlen D, et al. Atherosclerosis. 2002 Mar;161(1):209-14. doi: 10.1016/s0021-9150(01)00632-3. Atherosclerosis. 2002. PMID: 11882334 - Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?
Heikkinen AM, Niskanen L, Ryynänen M, Komulainen MH, Tuppurainen MT, Parviainen M, Saarikoski S. Heikkinen AM, et al. Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):402-7. doi: 10.1161/01.atv.19.2.402. Arterioscler Thromb Vasc Biol. 1999. PMID: 9974425 Clinical Trial. - Relationship between apolipoprotein E polymorphism, menopausal symptoms, and serum lipids during hormone replacement therapy.
Somekawa Y, Wakabayashi A. Somekawa Y, et al. Eur J Obstet Gynecol Reprod Biol. 1998 Aug;79(2):185-91. doi: 10.1016/s0301-2115(98)00008-6. Eur J Obstet Gynecol Reprod Biol. 1998. PMID: 9720839 - Association of apolipoprotein E genotypes with lipid levels and coronary risk.
Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, Keavney B, Collins R, Wiman B, de Faire U, Danesh J. Bennet AM, et al. JAMA. 2007 Sep 19;298(11):1300-11. doi: 10.1001/jama.298.11.1300. JAMA. 2007. PMID: 17878422 Review. - APO E gene and gene-environment effects on plasma lipoprotein-lipid levels.
Hagberg JM, Wilund KR, Ferrell RE. Hagberg JM, et al. Physiol Genomics. 2000 Dec 18;4(2):101-108. doi: 10.1152/physiolgenomics.2000.4.2.101. Physiol Genomics. 2000. PMID: 11120871 Review.
Cited by
- Apolipoprotein E gene polymorphism and its effect on anthropometric measures in normoglycemic subjects and type 2 diabetes.
Tabatabaei-Malazy O, Fakhrzadeh H, Qorbani M, Amiri P, Larijani B, Tavakkoly-Bazzaz J, Amoli MM. Tabatabaei-Malazy O, et al. J Diabetes Metab Disord. 2012 Oct 8;11(1):18. doi: 10.1186/2251-6581-11-18. J Diabetes Metab Disord. 2012. PMID: 23497440 Free PMC article. - Do long-term HDL-C declines associated with a first birth vary by apo E phenotype? The Coronary Artery Risk Development in Young Adults (CARDIA) study.
Gunderson EP, Whitmer RA, Lewis CE, Quesenberry CP, West DS, Sidney S. Gunderson EP, et al. J Womens Health (Larchmt). 2005 Dec;14(10):917-28. doi: 10.1089/jwh.2005.14.917. J Womens Health (Larchmt). 2005. PMID: 16372893 Free PMC article. - Role of estrogen in women's Alzheimer's disease risk as modified by APOE.
Valencia-Olvera AC, Maldonado Weng J, Christensen A, LaDu MJ, Pike CJ. Valencia-Olvera AC, et al. J Neuroendocrinol. 2023 Feb;35(2):e13209. doi: 10.1111/jne.13209. Epub 2022 Nov 24. J Neuroendocrinol. 2023. PMID: 36420620 Free PMC article. Review. - Pharmacogenetics of Lipid-lowering Therapies.
Ordovas JM, Shen H. Ordovas JM, et al. Curr Atheroscler Rep. 2002 May;4(3):183-92. doi: 10.1007/s11883-002-0018-2. Curr Atheroscler Rep. 2002. PMID: 11931715 Review. - Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype.
Barberger-Gateau P, Samieri C, Féart C, Plourde M. Barberger-Gateau P, et al. Curr Alzheimer Res. 2011 Aug;8(5):479-91. doi: 10.2174/156720511796391926. Curr Alzheimer Res. 2011. PMID: 21605054 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous